Physician profile

Edward T Downing

Pulmonary Disease · Syracuse, NY

NPI 1811939069

$2,131.57

in general payments reported to CMS, 2019-2025

19 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$25.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $590.70 2019-2020
Genentech USA, INC. $306.92 2019-2020
Boehringer Ingelheim Pharmaceuticals, INC. $302.69 2019-2020
Astrazeneca Pharmaceuticals LP $193.62 2019-2020
Grifols USA, LLC $167.75 2019-2020
Teva Pharmaceuticals USA, INC. $115.32 2019
Inspire Medical Systems, INC. $111.68 2019
Insmed, INC. $59.73 2019
Genzyme Corporation $45.45 2019
Bayer Healthcare Pharmaceuticals INC. $34.71 2019-2020
Actelion Pharmaceuticals US, INC. $34.67 2019-2020
Circassia INC. $31.34 2019
Mallinckrodt Hospital Products INC. $28.27 2020
Baxter Healthcare $25.06 2023 Hillrom - Life 2000 Ventilation System
Shire North American Group INC $24.77 2019
Show all 19 companies
CompanyGeneral paymentsYearsTop products
Regeneron Healthcare Solutions, INC. $18.89 2019
Novartis Pharmaceuticals Corporation $17.68 2019
Mylan Specialty L.P. $11.21 2019
Optinose US, INC. $11.11 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Edward T Downing

$2,131.57

in general payments reported 2019-2025

Years
2019-2023
Top company
Glaxosmithkline, LLC.

https://glasscript.com/doctor/173474/edward-t-downing

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.